BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1833 related articles for article (PubMed ID: 33350025)

  • 1. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
    Abdelrahman Z; Li M; Wang X
    Front Immunol; 2020; 11():552909. PubMed ID: 33013925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.
    Zhu Z; Lian X; Su X; Wu W; Marraro GA; Zeng Y
    Respir Res; 2020 Aug; 21(1):224. PubMed ID: 32854739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
    Elrashdy F; Redwan EM; Uversky VN
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].
    Liu M; Feng RE; Li Q; Zhang HK; Wang YG
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):511-516. PubMed ID: 32392945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
    Sarkar JP; Saha I; Seal A; Maity D; Maulik U
    Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa.
    Ahmed AE
    J Med Virol; 2020 Oct; 92(10):1753-1754. PubMed ID: 32270498
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.
    Jiang C; Yao X; Zhao Y; Wu J; Huang P; Pan C; Liu S; Pan C
    Microbes Infect; 2020; 22(6-7):236-244. PubMed ID: 32405236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: Look to the Future, Learn from the Past.
    Cheng ZJ; Qu HQ; Tian L; Duan Z; Hakonarson H
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33138262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS and MERS: recent insights into emerging coronaviruses.
    de Wit E; van Doremalen N; Falzarano D; Munster VJ
    Nat Rev Microbiol; 2016 Aug; 14(8):523-34. PubMed ID: 27344959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome.
    Hui DS; Zumla A; Tang JW
    Curr Opin Pulm Med; 2021 May; 27(3):146-154. PubMed ID: 33660619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
    Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
    FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
    Monroy-Gómez J; Torres-Fernández O
    Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
    Petersen E; Koopmans M; Go U; Hamer DH; Petrosillo N; Castelli F; Storgaard M; Al Khalili S; Simonsen L
    Lancet Infect Dis; 2020 Sep; 20(9):e238-e244. PubMed ID: 32628905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.